196 related articles for article (PubMed ID: 10518231)
41. Introductory trial of the once-a-month injectable contraceptive, Cyclofem, in Indonesia.
Pandi SP; Hadjar LN; Prihyugiharto T
Adv Contracept; 1993 Mar; 9(1):33-40. PubMed ID: 8342452
[TBL] [Abstract][Full Text] [Related]
42. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
43. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
44. A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature.
Simbar M; Tehrani FR; Hashemi Z; Zham H; Fraser IS
J Fam Plann Reprod Health Care; 2007 Oct; 33(4):271-6. PubMed ID: 17925114
[TBL] [Abstract][Full Text] [Related]
45. A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial.
Dunson TR; McLaurin VL; Israngkura B; Leelapattana B; Mukherjee R; Perez-Palacios G; Saleh AA
Contraception; 1993 Aug; 48(2):109-19. PubMed ID: 8403908
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of once-a-month injectable contraceptives.
Garza-Flores J
Contraception; 1994 Apr; 49(4):347-59. PubMed ID: 8013219
[TBL] [Abstract][Full Text] [Related]
47. Mesigyna once-a-month combined injectable contraceptive: experience in Latin America.
Bassol S; Cravioto MC; Durand M; Bailon R; Carranza S; Fugarolas J; Gaona R; Parada LM; Celis C; Santoyo S; Garza-Flores J; Vazquez L; Lopez C; Gurucharri C; Novelli J; Carneiro de Oliveira H; Mendez J; de Andrade ME; de Mello NR; de Melo K; Chada E; Yassle ME; Castañeda A; Gomez P; Arboleda C; Trujillo L; Bucheli R; Hidalgo I; Olavide R; Parejarios J; Succar J; Reyes-Marquez R; Albrecht G
Contraception; 2000 May; 61(5):309-16. PubMed ID: 10906501
[TBL] [Abstract][Full Text] [Related]
48. Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route.
Coutinho EM; O'Dwyer E; Barbosa IC; Gu ZP; Shaaban MM; Aboul-Oyoon M; Abdel Aleem H
Contraception; 1995 Jun; 51(6):355-8. PubMed ID: 7554976
[TBL] [Abstract][Full Text] [Related]
49. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive.
Jain JK; Ota F; Mishell DR
Contraception; 2000 Mar; 61(3):195-8. PubMed ID: 10827333
[TBL] [Abstract][Full Text] [Related]
50. Weight variation in users of the once-a-month injectable contraceptive Cyclofem.
Bahamondes L; Diaz J; Petta C; Hall P
Adv Contracept; 1998 Dec; 14(4):185-92. PubMed ID: 10075287
[TBL] [Abstract][Full Text] [Related]
51. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
[TBL] [Abstract][Full Text] [Related]
52. A clinical trial of Neo Sampoon vaginal tablets and Emko foam in Alexandria, Egypt.
Youssef H; Crofton VA; Smith SC; Siemens AJ
Contraception; 1987 Feb; 35(2):101-10. PubMed ID: 3297482
[TBL] [Abstract][Full Text] [Related]
53. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
54. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
Fraser IS
Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
[TBL] [Abstract][Full Text] [Related]
55. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
Canto de Cetina TE; Luna MO; Cetina Canto JA; Bassol S
Contraception; 2004 Feb; 69(2):115-9. PubMed ID: 14759615
[TBL] [Abstract][Full Text] [Related]
56. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
Balogun OR; Raji HO
Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621
[TBL] [Abstract][Full Text] [Related]
57. Some metabolic and hormonal changes in women using long acting injectable contraceptives.
Abdel-sayed WS; Toppozada HK; Said SA; El-sayed OK
Alex J Pharm Sci; 1989 Mar; 3(1):29-32. PubMed ID: 12316139
[TBL] [Abstract][Full Text] [Related]
58. Acceptability study of the two versus three monthly injectable contraceptives.
Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
[TBL] [Abstract][Full Text] [Related]
59. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
[TBL] [Abstract][Full Text] [Related]
60. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
Smit J; McFadyen L; Zuma K; Preston-Whyte E
Soc Sci Med; 2002 Nov; 55(9):1511-22. PubMed ID: 12297238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
